Skip to main content
Top
Published in: Endocrine 2/2016

01-11-2016 | Original Article

Two-miRNA classifiers differentiate mutation-negative follicular thyroid carcinomas and follicular thyroid adenomas in fine needle aspirations with high specificity

Published in: Endocrine | Issue 2/2016

Login to get access

Abstract

Diagnosis of thyroid by fine needle aspiration is challenging for the “indeterminate” category and can be supported by molecular testing. We set out to identify miRNA markers that could be used in a diagnostic setting to improve the discrimination of mutation-negative indeterminate fine needle aspirations. miRNA high-throughput sequencing was performed for freshly frozen tissue samples of 19 RAS and PAX8/PPARG mutation-negative follicular thyroid carcinomas, and 23 RAS and PAX8/PPARG mutation-negative follicular adenomas. Differentially expressed miRNAs were validated by quantitative polymerase chain reaction in a set of 44 fine needle aspiration samples representing 24 follicular thyroid carcinomas and 20 follicular adenomas. Twenty-six miRNAs characterized by a significant differential expression between follicular thyroid carcinomas and follicular adenomas were identified. Nevertheless, since no single miRNA had satisfactory predictive power, classifiers comprising two differentially expressed miRNAs were designed with the aim to improve the classification. Six two-miRNA classifiers were established and quantitative polymerase chain reaction validated in fine needle aspiration samples. Four out of six classifiers were characterized by a high specificity (≥94 %). The best two-miRNA classifier (miR-484/miR-148b-3p) identified thyroid malignancy with a sensitivity of 89 % and a specificity of 87 %. The high-throughput sequencing allowed the identification of subtle differences in the miRNA expression profiles of follicular thyroid carcinomas and follicular adenomas. While none of the differentially expressed miRNAs could be used as a stand-alone malignancy marker, the validation results for two-miRNA classifiers in an independent set of fine needle aspirations are very promising. The ultimate evaluation of these classifiers for their capability of discriminating mutation-negative indeterminate fine needle aspirations will require the evaluation of a sufficiently large number of fine needle aspirations with histological confirmation.
Appendix
Available only for authorised users
Literature
1.
go back to reference H. Gharib, E. Papini, R. Paschke, D.S. Duick, R. Valcavi, L. Hegedus, P. Vitti, American Association of clinical endocrinologists, Italian Association of clinical endocrinologists and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr. Pract. 16, 1–43 (2010)CrossRefPubMed H. Gharib, E. Papini, R. Paschke, D.S. Duick, R. Valcavi, L. Hegedus, P. Vitti, American Association of clinical endocrinologists, Italian Association of clinical endocrinologists and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr. Pract. 16, 1–43 (2010)CrossRefPubMed
2.
go back to reference R. Paschke, L. Hegedus, E. Alexander, R. Valcavi, E. Papini, H. Gharib, Thyroid nodule guidelines: agreement, disagreement and need for future research. Nat. Rev. Endocrinol. 7, 354–361 (2011)CrossRefPubMed R. Paschke, L. Hegedus, E. Alexander, R. Valcavi, E. Papini, H. Gharib, Thyroid nodule guidelines: agreement, disagreement and need for future research. Nat. Rev. Endocrinol. 7, 354–361 (2011)CrossRefPubMed
3.
go back to reference B.R. Haugen, E.K. Alexander, K.C. Bible, G.M. Doherty, S.J. Mandel, Y.E. Nikiforov, F. Pacini, G.W. Randolph, A.M. Sawka, M. Schlumberger, K.G. Schuff, S.I. Sherman, J.A. Sosa, D.L. Steward, R.M. Tuttle, L. Wartofsky, 2015 American Thyroid Association Management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26, 1–133 (2016)CrossRefPubMed B.R. Haugen, E.K. Alexander, K.C. Bible, G.M. Doherty, S.J. Mandel, Y.E. Nikiforov, F. Pacini, G.W. Randolph, A.M. Sawka, M. Schlumberger, K.G. Schuff, S.I. Sherman, J.A. Sosa, D.L. Steward, R.M. Tuttle, L. Wartofsky, 2015 American Thyroid Association Management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26, 1–133 (2016)CrossRefPubMed
4.
go back to reference Z.W. Baloch, V.A. LiVolsi, S.L. Asa, J. Rosai, M.J. Merino, G. Randolph, P. Vielh, R.M. DeMay, M.K. Sidawy, W.J. Frable, Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute thyroid fine-needle aspiration state of the science conference. Diagn. Cytopathol. 36, 425–437 (2008)CrossRefPubMed Z.W. Baloch, V.A. LiVolsi, S.L. Asa, J. Rosai, M.J. Merino, G. Randolph, P. Vielh, R.M. DeMay, M.K. Sidawy, W.J. Frable, Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute thyroid fine-needle aspiration state of the science conference. Diagn. Cytopathol. 36, 425–437 (2008)CrossRefPubMed
5.
go back to reference M. Afkhami, A. Karunamurthy, S. Chiosea, M.N. Nikiforova, R. Seethala, Y.E. Nikiforov, C. Coyne, Histopathologic and clinical characterization of thyroid tumors carrying the BRAF(K601E) mutation. Thyroid 26, 242–247 (2016)CrossRefPubMed M. Afkhami, A. Karunamurthy, S. Chiosea, M.N. Nikiforova, R. Seethala, Y.E. Nikiforov, C. Coyne, Histopathologic and clinical characterization of thyroid tumors carrying the BRAF(K601E) mutation. Thyroid 26, 242–247 (2016)CrossRefPubMed
6.
go back to reference M. Eszlinger, R. Paschke, Molecular fine-needle aspiration biopsy diagnosis of thyroid nodules by tumor specific mutations and gene expression patterns. Mol. Cell. Endocrinol. 322, 29–37 (2010)CrossRefPubMed M. Eszlinger, R. Paschke, Molecular fine-needle aspiration biopsy diagnosis of thyroid nodules by tumor specific mutations and gene expression patterns. Mol. Cell. Endocrinol. 322, 29–37 (2010)CrossRefPubMed
7.
go back to reference C. Ferraz, M. Eszlinger, R. Paschke, Current state and future perspective of molecular diagnosis of fine-needle aspiration biopsy of thyroid nodules. J. Clin. Endocrinol. Metab. 96, 2016–2026 (2011)CrossRefPubMed C. Ferraz, M. Eszlinger, R. Paschke, Current state and future perspective of molecular diagnosis of fine-needle aspiration biopsy of thyroid nodules. J. Clin. Endocrinol. Metab. 96, 2016–2026 (2011)CrossRefPubMed
8.
go back to reference L. Lodewijk, A.M. Prins, J.W. Kist, G.D. Valk, O. Kranenburg, I.H. Rinkes, M.R. Vriens, The value of miRNA in diagnosing thyroid cancer: a systematic review. Cancer Biomark. 11, 229–238 (2012)PubMed L. Lodewijk, A.M. Prins, J.W. Kist, G.D. Valk, O. Kranenburg, I.H. Rinkes, M.R. Vriens, The value of miRNA in diagnosing thyroid cancer: a systematic review. Cancer Biomark. 11, 229–238 (2012)PubMed
9.
go back to reference M. Rossing, Classification of follicular cell-derived thyroid cancer by global RNA profiling. J. Mol. Endocrinol. 50, R39–R51 (2013)CrossRefPubMed M. Rossing, Classification of follicular cell-derived thyroid cancer by global RNA profiling. J. Mol. Endocrinol. 50, R39–R51 (2013)CrossRefPubMed
10.
go back to reference T. Stokowy, B. Wojtas, K. Fujarewicz, B. Jarzab, M. Eszlinger, R. Paschke, miRNAs with the potential to distinguish follicular thyroid carcinomas from benign follicular thyroid tumors—results of a meta-analysis. Horm. Metab. Res. 46, 171–180 (2013) T. Stokowy, B. Wojtas, K. Fujarewicz, B. Jarzab, M. Eszlinger, R. Paschke, miRNAs with the potential to distinguish follicular thyroid carcinomas from benign follicular thyroid tumors—results of a meta-analysis. Horm. Metab. Res. 46, 171–180 (2013)
11.
go back to reference T. Stokowy, M. Eszlinger, M. Swierniak, K. Fujarewicz, B. Jarzab, R. Paschke, K. Krohn, Analysis options for high-throughput sequencing in miRNA expression profiling. BMC Res. Notes 7, 144 (2014)CrossRefPubMedPubMedCentral T. Stokowy, M. Eszlinger, M. Swierniak, K. Fujarewicz, B. Jarzab, R. Paschke, K. Krohn, Analysis options for high-throughput sequencing in miRNA expression profiling. BMC Res. Notes 7, 144 (2014)CrossRefPubMedPubMedCentral
12.
go back to reference Cancer Genome Atlas Research Network. Integrated genomic characterization of papillary thyroid carcinoma. Cell. 159, 676–690 (2014) Cancer Genome Atlas Research Network. Integrated genomic characterization of papillary thyroid carcinoma. Cell. 159, 676–690 (2014)
13.
go back to reference M. Swierniak, A. Wojcicka, M. Czetwertynska, E. Stachlewska, M. Maciag, W. Wiechno, B. Gornicka, M. Bogdanska, L. Koperski, A. de la Chapelle, K. Jazdzewski, In-depth characterization of the microRNA transcriptome in normal thyroid and papillary thyroid carcinoma. J. Clin. Endocrinol. Metab. 98, E1401–E1409 (2013)CrossRefPubMed M. Swierniak, A. Wojcicka, M. Czetwertynska, E. Stachlewska, M. Maciag, W. Wiechno, B. Gornicka, M. Bogdanska, L. Koperski, A. de la Chapelle, K. Jazdzewski, In-depth characterization of the microRNA transcriptome in normal thyroid and papillary thyroid carcinoma. J. Clin. Endocrinol. Metab. 98, E1401–E1409 (2013)CrossRefPubMed
14.
go back to reference M. Eszlinger, L. Hegedus, R. Paschke, : Ruling in or ruling out thyroid malignancy by molecular diagnostics of thyroid nodules. Best Pract. Res. Clin. Endocrinol. Metab. 28, 545–557 (2014)CrossRefPubMed M. Eszlinger, L. Hegedus, R. Paschke, : Ruling in or ruling out thyroid malignancy by molecular diagnostics of thyroid nodules. Best Pract. Res. Clin. Endocrinol. Metab. 28, 545–557 (2014)CrossRefPubMed
15.
go back to reference M. Martin, Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet. journal. 17, 10–12 (2011)CrossRef M. Martin, Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet. journal. 17, 10–12 (2011)CrossRef
17.
go back to reference S. Griffiths-Jones, R.J. Grocock, D.S. van, A. Bateman, A.J. Enright, miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res. 34, D140–D144 (2006)CrossRefPubMed S. Griffiths-Jones, R.J. Grocock, D.S. van, A. Bateman, A.J. Enright, miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res. 34, D140–D144 (2006)CrossRefPubMed
19.
go back to reference H. Li, B. Handsaker, A. Wysoker, T. Fennell, J. Ruan, N. Homer, G. Marth, G. Abecasis, R. Durbin, The sequence alignment/map format and SAMtools. Bioinformatics 25, 2078–2079 (2009)CrossRefPubMedPubMedCentral H. Li, B. Handsaker, A. Wysoker, T. Fennell, J. Ruan, N. Homer, G. Marth, G. Abecasis, R. Durbin, The sequence alignment/map format and SAMtools. Bioinformatics 25, 2078–2079 (2009)CrossRefPubMedPubMedCentral
20.
21.
go back to reference R.C. Gentleman, V.J. Carey, D.M. Bates, B. Bolstad, M. Dettling, S. Dudoit, B. Ellis, L. Gautier, Y. Ge, J. Gentry, K. Hornik, T. Hothorn, W. Huber, S. Iacus, R. Irizarry, F. Leisch, C. Li, M. Maechler, A.J. Rossini, G. Sawitzki, C. Smith, G. Smyth, L. Tierney, J.Y. Yang, J. Zhang, Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 5, R80 (2004)CrossRefPubMedPubMedCentral R.C. Gentleman, V.J. Carey, D.M. Bates, B. Bolstad, M. Dettling, S. Dudoit, B. Ellis, L. Gautier, Y. Ge, J. Gentry, K. Hornik, T. Hothorn, W. Huber, S. Iacus, R. Irizarry, F. Leisch, C. Li, M. Maechler, A.J. Rossini, G. Sawitzki, C. Smith, G. Smyth, L. Tierney, J.Y. Yang, J. Zhang, Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 5, R80 (2004)CrossRefPubMedPubMedCentral
22.
go back to reference T. Stokowy, B. Wojtas, J. Krajewska, E. Stobiecka, H. Dralle, T. Musholt, S. Hauptmann, D. Lange, L. Hegedus, B. Jarzab, K. Krohn, R. Paschke, M. Eszlinger, A two miRNA classifier differentiates follicular thyroid carcinomas from follicular thyroid adenomas. Mol. Cell. Endocrinol. 399, 43–49 (2015)CrossRefPubMed T. Stokowy, B. Wojtas, J. Krajewska, E. Stobiecka, H. Dralle, T. Musholt, S. Hauptmann, D. Lange, L. Hegedus, B. Jarzab, K. Krohn, R. Paschke, M. Eszlinger, A two miRNA classifier differentiates follicular thyroid carcinomas from follicular thyroid adenomas. Mol. Cell. Endocrinol. 399, 43–49 (2015)CrossRefPubMed
23.
go back to reference M. Eszlinger, A. Krogdahl, S. Munz, C. Rehfeld, E.M. Precht Jensen, C. Ferraz, E. Bosenberg, N. Drieschner, M. Scholz, L. Hegedus, R. Paschke, Impact of molecular screening for point mutations and rearrangements in routine air-dried fine-needle aspiration samples of thyroid nodules. Thyroid. 24, 305–313 (2014)CrossRefPubMed M. Eszlinger, A. Krogdahl, S. Munz, C. Rehfeld, E.M. Precht Jensen, C. Ferraz, E. Bosenberg, N. Drieschner, M. Scholz, L. Hegedus, R. Paschke, Impact of molecular screening for point mutations and rearrangements in routine air-dried fine-needle aspiration samples of thyroid nodules. Thyroid. 24, 305–313 (2014)CrossRefPubMed
24.
go back to reference C. Ferraz, C. Rehfeld, A. Krogdahl, E.M. Precht Jensen, E. Bosenberg, F. Narz, L. Hegedus, R. Paschke, M. Eszlinger, Detection of PAX8/PPARG and RET/PTC rearrangements is feasible in routine air-dried fine needle aspiration smears. Thyroid 22, 1025–1030 (2012)CrossRefPubMedPubMedCentral C. Ferraz, C. Rehfeld, A. Krogdahl, E.M. Precht Jensen, E. Bosenberg, F. Narz, L. Hegedus, R. Paschke, M. Eszlinger, Detection of PAX8/PPARG and RET/PTC rearrangements is feasible in routine air-dried fine needle aspiration smears. Thyroid 22, 1025–1030 (2012)CrossRefPubMedPubMedCentral
25.
go back to reference K.D. Burman, L. Wartofsky, Clinical practice: thyroid nodules. N. Engl. J. Med. 373, 2347–2356 (2015)CrossRefPubMed K.D. Burman, L. Wartofsky, Clinical practice: thyroid nodules. N. Engl. J. Med. 373, 2347–2356 (2015)CrossRefPubMed
26.
27.
go back to reference Y.E. Nikiforov, N.P. Ohori, S.P. Hodak, S.E. Carty, S.O. LeBeau, R.L. Ferris, L. Yip, R.R. Seethala, M.E. Tublin, M.T. Stang, C. Coyne, J.T. Johnson, A.F. Stewart, M.N. Nikiforova, Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples. J. Clin. Endocrinol. Metab. 96, 3390–3397 (2011)CrossRefPubMedPubMedCentral Y.E. Nikiforov, N.P. Ohori, S.P. Hodak, S.E. Carty, S.O. LeBeau, R.L. Ferris, L. Yip, R.R. Seethala, M.E. Tublin, M.T. Stang, C. Coyne, J.T. Johnson, A.F. Stewart, M.N. Nikiforova, Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples. J. Clin. Endocrinol. Metab. 96, 3390–3397 (2011)CrossRefPubMedPubMedCentral
28.
go back to reference M. Eszlinger, S. Piana, A. Moll, E. Bosenberg, A. Bisagni, A. Ciarrocchi, M. Ragazzi, R. Paschke, Molecular testing of thyroid fine needle aspirations (FNA) improves pre-surgical diagnosis and supports the histological identification of minimally invasive follicular thyroid carcinomas. Thyroid 25, 401–409 (2015)CrossRefPubMed M. Eszlinger, S. Piana, A. Moll, E. Bosenberg, A. Bisagni, A. Ciarrocchi, M. Ragazzi, R. Paschke, Molecular testing of thyroid fine needle aspirations (FNA) improves pre-surgical diagnosis and supports the histological identification of minimally invasive follicular thyroid carcinomas. Thyroid 25, 401–409 (2015)CrossRefPubMed
Metadata
Title
Two-miRNA classifiers differentiate mutation-negative follicular thyroid carcinomas and follicular thyroid adenomas in fine needle aspirations with high specificity
Publication date
01-11-2016
Published in
Endocrine / Issue 2/2016
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-016-1021-7

Other articles of this Issue 2/2016

Endocrine 2/2016 Go to the issue